1.Surgical management on portal hypertension with esophageal varices.
Hyun Jang KIM ; Ho Chul PARK ; Sung Wha HONG
Journal of the Korean Surgical Society 1992;42(5):607-616
No abstract available.
Esophageal and Gastric Varices*
;
Hypertension, Portal*
2.A Case of Esophageal Variceal Bleeding in a Child Secondary to Portal Hypertension Associated with Cavernous Transformation of the Portal Vein Suggesting Extrahepatic Portal Obstruction.
Sun Yang HONG ; Tae Won OH ; Jeong Kook LEE ; Hahng LEE ; Keun Soo LEE ; Seok Chol JEON ; Heung Suk SEO
Journal of the Korean Pediatric Society 1990;33(10):1406-1412
No abstract available.
Child*
;
Esophageal and Gastric Varices*
;
Humans
;
Hypertension, Portal*
;
Portal Vein*
3.Idiopathic portal hypertension.
Yong Joon SEO ; Young Kil CHOI ; Sang Hyo KIM
Journal of the Korean Surgical Society 1993;45(2):249-255
No abstract available.
Hypertension, Portal*
5.A Pericardiophrenic Collateral Pathway in Portal Hypertension
Dong Hun KIM ; Hancheol JO ; Jeongseok YUN
Journal of Acute Care Surgery 2019;9(1):25-26
No abstract available.
Hypertension, Portal
6.A Case of Portal Vein and Splenic Vein Occlusion after Endoscopic Variceal Occlusion Therapy in Gastric Variceal Bleeding.
Eun Jeong KANG ; Soo Young PARK ; Yu Rim LEE ; Chang Yeon KIM ; Sun Young AHN ; Jung Gil PARK ; Hyun Seok LEE ; Won Young TAK ; Young Oh KWEON
Keimyung Medical Journal 2014;33(2):164-168
Acute gastric variceal bleeding is one of the most serious complications in portal hypertension, and is associated with high mortality and morbidity. Endoscopic variceal obturation (EVO) using Histoacryl(R) (n-butyl-2-cyanoacrylate) has been accepted as an effective hemostatic procedure in acute gastric variceal bleeding. However, EVO is not a widely performed because of technical difficulties and complications such as mucosal ulceration, perforation, and systemic embolism. Herein, we report a patient who developed hepatic failure caused by portal vein occlusion by Histoacryl(R) injection for management of gastric variceal bleeding.
Embolism
;
Esophageal and Gastric Varices*
;
Humans
;
Hypertension, Portal
;
Liver Failure
;
Mortality
;
Portal Vein*
;
Splenic Vein*
;
Ulcer
7.Baveno VII - Renewing consensus in portal hypertension: personalized care for portal hypertension.
Xiao Mei LI ; Bo Han LUO ; Zheng Yu WANG ; Jie YUAN ; Guo Hong HAN
Chinese Journal of Hepatology 2022;30(1):21-29
The Baveno VII workshop held in October 2021 was featured by the subject of personalized care in portal hypertension. The workshop focused on the following 9 topics including: the relevance and indications for measuring the hepatic venous pressure gradient as a gold standard; the use of non-invasive tools for the diagnosis of compensated advanced chronic liver disease and clinically significant portal hypertension; the impact of etiological and of non-etiological therapies in the course of cirrhosis; the prevention of the first episode of decompensation; the management of the acute bleeding episode; the prevention of further decompensation; as well as the diagnosis and management of splanchnic vein thrombosis and other vascular disorders of the liver. This essay provides a compilation and summary of recommendations regarding the abovementioned topics, and presents the most recent research proceedings and the corresponding consensus to our readers.
Consensus
;
Esophageal and Gastric Varices
;
Humans
;
Hypertension, Portal/therapy*
;
Liver Cirrhosis/therapy*
;
Portal Pressure
9.Clinical application of hepatic venous pressure gradient to predict early bleeding after esophageal variceal ligation.
Bingju LIU ; Lichun WU ; Guangchuan WANG ; Hua FENG ; Jinhua HU ; Yi CUI ; Chunqing ZHANG
Chinese Journal of Hepatology 2015;23(1):50-54
OBJECTIVETo investigate the predictive value of hepatic venous pressure gradient (HVPG) for early bleeding after esophageal variceal ligation (EVL) by analyzing the differences in HVPG in patients with and without post-EVL bleeding.
METHODSThe medical records of patients who had been diagnosed with cirrhosis and esophageal varices and who had pre-EVL HVPG measurement data were surveyed. The study population included 105 patients from October 2010 to March 2014. Data of HVPG value, previous treatment history, endoscopic manifestation, and whether bleeding and serious complications occurred within 2 weeks after the ligation procedure were investigated as independent risk factors.
STATISTICAL METHODSincluded the chi-square test and Wilcoxon test, logistic regression modeling and receiver operating characteristic (ROC) analysis using the SPSS software version 16.
RESULTSOnly HVPG value was identified as an independent risk factor of early bleeding after EVL.According to the ROC analysis, the area under the curve (AUC) of HVPG for early bleeding after EVL was 0.866; when HVPG was more than or equal to 16 mmHg, AUC was 0.838. The sensitivity was 90.9% and the specificity was 76.4%.
CONCLUSIONHVPG is an independent factor of early bleeding after EVL and when HVPG cut-off value of more than or equal to 16 mmHg is used the predictive ability has certain accuracy and high sensitivity and specificity.
Endoscopy, Gastrointestinal ; Esophageal and Gastric Varices ; Gastrointestinal Hemorrhage ; Humans ; Hypertension, Portal ; Ligation ; Liver Cirrhosis ; Portal Pressure ; ROC Curve ; Risk Factors
Result Analysis
Print
Save
E-mail